Interactive assay details for monoacylglycerols, N-acylethanolamines, N-arachidonoyl glycine, and oleamide, organized around their major biosynthesis and degradation pathways.
13 analytes
The pathway graphic emphasizes the best-established enzymatic relationships, especially the classical AEA and 2-AG pathways, while grouping related lipids where direct one-to-one conversions would overstate the evidence.
Interactive pathway details available
Endocannabinoids
Select an analyte from the list below. The information panel updates immediately, and the pathway graphic can be opened to show where each compound sits within broader biosynthesis and degradation biology.
Clicking a compound from the list or pathway updates the detail panel and scrolls to it, making the change more obvious than a passive panel lower on the page.
Endocannabinoid biosynthesis and degradation
The left column shows upstream lipid contexts, the center column shows the measured analytes, and the right column highlights the best-established hydrolytic or oxidative fates. For related lipids, common pathway families are shown without implying unsupported direct conversion between every member.
Documented metabolic route Shared pathway or precursor Structural relationship only
Gold-framed nodes are measured analytes; pale blue nodes show unmeasured precursor or product context. Arrows indicate established or proposed metabolic routes as labeled, not metabolic flux. Dashed branches group analytes sharing pathway machinery; dotted connections mark structural similarity, not conversion. The AEA → NAGly route is a reported oxidative pathway, not the only known source of NAGly.